Cytomegalovirus-specific CD154-expressing T Cells are Present Before Transplantation in Cytomegalovirus-seronegative Recipients and Predict Early Cytomegalovirus DNAemia
CMV-specific T cells that express CD154 demonstrate protective levels of CMI in half of all seronegative recipients and can be used to optimize antiviral prophylaxis across all risk categories.
Authors
- Mylarappa Ningappa (ORCID: https://orcid.org/0000-0002-5238-8663)
- Ajay Khanna (ORCID: https://orcid.org/0000-0002-9813-3797)
- Brandon W. Higgs (ORCID: https://orcid.org/0000-0002-2951-0245)
- George Vincent Mazariegos (ORCID: https://orcid.org/0000-0002-2624-8632)
- M. G. Michaels
- Dawn Wilkerson
- Brianna Spishock
- Tamara Fazzolare
- Chethan Ashokkumar (ORCID: https://orcid.org/0000-0001-6508-3407)
- Vikram Raghu (ORCID: https://orcid.org/0000-0002-6555-9732)
- Lisa Remaley
- Rakesh Sindhi (ORCID: https://orcid.org/0000-0001-8525-6694)
- Paul Morgan (ORCID: https://orcid.org/0000-0003-1439-9545)
- G. C. Bond
- Armando Ganoza
- Kyle Soltys
- Michael Green
Institutions
- Children's Hospital of Pittsburgh (US)
- Plexision (United States) (US)
Publication Details
- Journal
- Transplantation Direct
- Published
- 2026-02-23
- DOI
- https://doi.org/10.1097/txd.0000000000001923
- Primary Topic
- Cytomegalovirus and herpesvirus research
- Type
- article
- Field-Weighted Citation Impact
- 0.00